Seeking Alpha

Epizyme beats by $0.11, beats on revenue

  • Epizyme (EPZM): Q2 EPS of -$0.25 beats by $0.11.
  • Revenue of $14.8M beats by $1.4M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector